NCT04496999 2022-10-06
HDMM
Insel Gruppe AG, University Hospital Bern
Phase 1 Terminated
Clinical Trials
3 trialsNCT03951961 2022-01-21
Midostaurin in MRD (Minimal Residual Disease) Positive Acute Myeloid Leukemia After Allogeneic Stem Cell Transplantation
University of Jena
Phase 2 Terminated
NCT00866281 2015-12-22
A Study of the Safety and Preliminary Efficacy of Oral Midostaurin (PKC412) in Relapsed or Refractory Pediatric Leukemia
Novartis
Phase 1/2 Terminated